<SEC-DOCUMENT>0001213900-25-108445.txt : 20251112
<SEC-HEADER>0001213900-25-108445.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251110205553
ACCESSION NUMBER:		0001213900-25-108445
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251110
EFFECTIVENESS DATE:		20251112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ping An Biomedical Co., Ltd.
		CENTRAL INDEX KEY:			0001897532
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291440
		FILM NUMBER:		251468014

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		22/F, CHINA UNITED PLAZA
		STREET 2:		1002-1008 TAI NAN WEST STREET
		CITY:			CHEUNG SHA WAN, KOWLOON
		NON US STATE TERRITORY:  	HONG KONG
		PROVINCE COUNTRY:   	K3
		ZIP:			0000
		BUSINESS PHONE:		852 9710 8044

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		22/F, CHINA UNITED PLAZA
		STREET 2:		1002-1008 TAI NAN WEST STREET
		CITY:			CHEUNG SHA WAN, KOWLOON
		NON US STATE TERRITORY:  	HONG KONG
		PROVINCE COUNTRY:   	K3
		ZIP:			0000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Majestic Ideal Holdings Ltd
		DATE OF NAME CHANGE:	20211206
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0264680-s8_pingan.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>As filed with the Securities
and Exchange Commission on November 10, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Registration No. 333- </B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PING AN BIOMEDICAL CO., LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cayman Islands</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>N/A</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of<BR>
incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<BR>
Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>22/F, China United Plaza, 1002-1008, Tai Nan
West Street,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cheung Sha Wan, Kowloon, Hong Kong</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PING AN BIOMEDICAL CO., LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2025 STOCK INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cogency Global Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>122 East 42nd Street, 18th Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10168</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212)&nbsp;947-7200</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, including zip code, and telephone
number, including area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer &#9746;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company &#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company &#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This registration statement on Form S-8 (this
&ldquo;Registration Statement&rdquo;) is filed by Ping An Biomedical Co., Ltd. (the &ldquo;Company&rdquo;) or the &ldquo;Registrant&rdquo;)
to register 4,050,000 ordinary shares, at par value US$0.0000625 per share (the &ldquo;Ordinary Shares&rdquo;), that may be issued under
the Company&rsquo;s 2025 Stock Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 1. PLAN INFORMATION*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE
PLAN ANNUAL INFORMATION*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the Note to Part I of Form S-8. The documents containing information specified in this Part I will be separately provided to the participants in the 2025 Stock Incentive Plan covered by this Registration Statement, as specified by Rule 428(b)(1) under the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following documents previously
filed by the Registrant with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of the Registrant&rsquo;s Ordinary Shares incorporated by reference in the Registrant&rsquo;s registration statement on </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1897532/000121390025064079/ea0249011-8a12b_majestic.htm">Form 8-A</A></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(File No. 001-42155) filed with the Commission on July 15, 2025, including any amendment and report subsequently filed for the purpose of updating that description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Registrant&rsquo;s Report of Foreign Private Issuer on Form 6-K furnished to the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025067174/ea0249994-6k_majestic.htm">July 24, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025068527/ea0250595-6k_majestic.htm">July 29, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025083733/ea0254772-6k_majestic.htm">September 3, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025087422/ea0257351-6k_majestic.htm">September 15, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1897532/000121390025091889/ea0258584-6k_majestic.htm">September 26, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025093049/ea0257340-6k_majestic.htm">September 29, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1897532/000121390025098254/ea0261043-6k_pingan.htm">October 14, 2025</A>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All documents subsequently
filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, after the date of this Registration Statement
and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have
been sold, or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be
a part hereof from the date of filing of such documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any statement contained in
a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of
this Registration Statement to the extent that a statement contained herein, or in any other subsequently filed document which also is
incorporated or deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or
superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 4. DESCRIPTION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 5. INTEREST OF NAMED EXPERTS AND COUNSEL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Companies Act of the
Cayman Islands does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy,
such as to provide indemnification against civil fraud or the consequences of committing a crime. The Registrant&rsquo;s amended and restated
memorandum and articles of association provide that that it shall indemnify its existing or former directors (including alternate director),
secretary and officers (including an investment adviser or an administrator or liquidator), and their personal representatives, against
all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such persons, other than by
reason of such person&rsquo;s dishonesty, willful default or fraud, in or about the conduct of the Registrant&rsquo;s business or affairs
or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the
foregoing, any costs, expenses, losses or liabilities incurred by such existing or former director (including alternate director), secretary
or officer in defending (whether successfully or otherwise) any civil, criminal, administrative or investigative proceedings (whether
threatened, pending or completed) concerning the Registrant or its affairs in any court or tribunal, whether in the Cayman Islands or
elsewhere.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the Registrant
has entered into indemnification agreements with its directors and executive officers that provide such persons with additional indemnification
beyond that provided in the Registrant&rsquo;s amended and restated memorandum and articles of association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 8. EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 90%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1897532/000121390024085251/ea020803702ex3-2_majestic.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Amended and Restated Memorandum and Articles of Association of the Registrant (incorporated herein by reference to Exhibit 3.2 to the registration statement on Form F-1 (File No. 333-282499), initially filed with the SEC on October 4, 2024)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1897532/000121390024085251/ea020803702ex4-1_majestic.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s Specimen Certificate for Ordinary Shares (incorporated herein by reference to Exhibit 4.1 to the registration statement on Form F-1 (File No. 333-282499), as amended, initially filed with the SEC on October 4, 2024)</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026468001ex5-1_pingan.htm">Opinion of Ogier, Cayman Islands counsel to the Registrant, regarding the validity of the ordinary shares being registered</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea026468001ex10-1_pingan.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025 Stock Incentive Plan</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea026468001ex23-1_pingan.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm (WWC, P.C.)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea026468001ex5-1_pingan.htm">Consent of Ogier (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#p_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on the signature page to this Registration Statement)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea026468001ex-fee_pingan.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table (filed herewith)</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ITEM 9. UNDERTAKINGS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned Registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration
Statement; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
material change to such information in the Registration Statement;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><I>provided</I>, <I>however</I>, that
paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of
the Exchange Act that are incorporated by reference in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="p_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in Hong Kong, on November 10, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ping An Biomedical Co., Ltd. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Pijun Liu</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pijun Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors, Chief Executive Officer and Executive Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">KNOW ALL PERSONS BY THESE
PRESENTS, that each person whose signature appears below constitutes and appoints Wai Lau as his or her true and lawful attorney-in-fact
and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all
capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same,
with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done
in connection therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to
be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities set forth below
on November 10, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Pijun Liu</I></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors, Chief Executive Officer and Executive Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pijun Liu</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Hongli Yang </I></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hongli Yang </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Qingxian Liu</I></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qingxian Liu</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jifeng Gao</I></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jifeng Gao</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Xianzhi Liu </I></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xianzhi Liu </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>SIGNATURE OF AUTHORIZED
REPRESENTATIVE IN THE UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Pursuant
to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of Intelligent Group Limited,
has signed this registration statement or amendment thereto in New York on November 10, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cogency Global Inc.</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized U.S. Representative</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Colleen A. De Vries</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen A. De Vries</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice-President on behalf of Cogency Global Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea026468001ex5-1_pingan.htm
<DESCRIPTION>OPINION OF OGIER, CAYMAN ISLANDS COUNSEL TO THE REGISTRANT, REGARDING THE VALIDITY OF THE ORDINARY SHARES BEING REGISTERED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;<IMG SRC="ex5-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="width: 47%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ping An Biomedical Co., Ltd. </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o - Conyers Trust Company</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Cayman) Limited, Cricket Square, Hutchins Drive, <BR>
PO Box 2681, Grand
    Cayman, KY1-1111,<BR>
 Cayman Islands</P></TD>
    <TD STYLE="width: 12%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 41%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>D&nbsp;&nbsp;</B></FONT><B>+852 3656 6054/ 3656 6061</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>E: </B></FONT><B>nathan.powell@ogier.com/<BR>
florence.chan@ogier.com</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Reference: FYC/MM/515817-00001</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">10 November 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ping An Biomedical Co., Ltd. (the Company)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as Cayman Islands counsel to the
Company in connection with the Company&rsquo;s registration statement on Form S-8, including all amendments or supplements thereto (the
<B>Form S-8</B>), as filed with the United States Securities and Exchange Commission (the <B>Commission</B>) under the United States Securities
Act of 1933, as amended (the <B>Act</B>) on or about the date hereof. The Form S-8 relates to the registration under the Securities Act
of the ordinary shares of a nominal or par value of US$0.0000625 each (each an <B>Ordinary Share</B>) to be issued pursuant to the Company&rsquo;s
2025 Stock Incentive Plan as approved by the board of directors of the Company on 23 October 2025 (the <B>2025 Stock Incentive Plan</B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless a contrary intention appears, all capitalised
terms used in this opinion have the respective meanings set forth in the Documents (as defined below). A reference to a Schedule is a
reference to a schedule to this opinion and the headings herein are for convenience only and do not affect the construction of this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">Documents examined</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">For the purposes of giving this opinion,
we have examined originals, copies, or drafts of the following documents (the <B>Documents</B>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the certificate of incorporation of the Company dated 3 November 2021 issued by the Registrar of Companies
of the Cayman Islands (the <B>Registrar</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(b)</TD><TD STYLE="text-align: justify">the certificate of incorporation on change of name of the Company dated 12 September 2025 issued by the
Registrar;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(c)</TD><TD STYLE="text-align: justify">the amended and restated memorandum and articles of association as adopted by special resolution passed
on 16 July 2025, and conditional upon and with effect from the completion of the Company's initial public offering of its Ordinary Shares
(the <B>Memorandum and Articles</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<table cellspacing="0" cellpadding="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 8pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-bottom: 4.25pt; padding-left: 5.4pt"><p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ogier</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Providing
    advice on British Virgin Islands, <BR>
Cayman Islands and Guernsey laws</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Floor
    11 Central Tower</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">28
    Queen&rsquo;s Road Central</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Central</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Hong
    Kong</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">T
    +852 3656 6000</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">F
    +852 3656 6001</font></p>
    <p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ogier.com</font></p></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 15%; padding-right: 5.4pt; padding-bottom: 4.25pt; padding-left: 5.4pt"><p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Partners</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nicholas
    Plowman</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nathan
    Powell</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Anthony
    Oakes</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Oliver
    Payne</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Kate
    Hodson</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">David
    Nelson</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Justin
    Davis</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Joanne
    Collett</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Dennis
    Li</font></p></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 15%; padding-right: 5.4pt; padding-bottom: 4.25pt; padding-left: 5.4pt"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cecilia
    Li</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Yuki
    Yan</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">David
    Lin</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Alan
    Wong</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Rachel
    Huang**</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Florence
    Chan*<sup>&Dagger;</sup></font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Richard
    Bennett**<sup>&Dagger;</sup></font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">James
    Bergstrom<sup>&Dagger;</sup></font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</font></p></td>
    <td style="font: 8pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-bottom: 4.25pt; padding-left: 5.4pt"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">*
    admitted in New Zealand</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt">**
    admitted in England and Wales</font></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup>&Dagger;</sup>
    not ordinarily resident in Hong Kong</font></p></td></tr>
  </table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">Page <B><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></B> of <B>4</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(d)</TD><TD STYLE="text-align: justify">the register of directors and officers of the Company dated as at 7 November 2025 (the <B>Register of
Directors</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(e)</TD><TD STYLE="text-align: justify">the shareholder list of the Company provided by the transfer agent of the Company as at 7 November 2025(together
with the Register of Directors, the <B>Registers</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(f)</TD><TD STYLE="text-align: justify">a copy of the written resolutions of all the directors of the Company dated 23 October 2025 approving,
among other things, the Company's adoption of the 2025 Stock Incentive Plan (the <B>Board Resolutions</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(g)</TD><TD STYLE="text-align: justify">a certificate from a director of the Company dated 10 November 2025 as to certain matters of fact (the
<B>Director's Certificate</B>);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(h)</TD><TD STYLE="text-align: justify">the Form S-8; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(i)</TD><TD STYLE="text-align: justify">a copy of the 2025 Stock Incentive Plan as exhibited to the Form S-8.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">2</TD><TD STYLE="text-align: justify">Assumptions</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">In giving this opinion we have relied
upon the assumptions set forth in this paragraph 2 without having carried out any independent investigation or verification in respect
of those assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(a)</TD><TD STYLE="text-align: justify">all original documents examined by us are authentic and complete;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(b)</TD><TD STYLE="text-align: justify">all copy documents examined by us (whether in facsimile, electronic or other form) conform to the originals
and those originals are authentic and complete;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(c)</TD><TD STYLE="text-align: justify">all signatures, seals, dates, stamps and markings (whether on original or copy documents) are genuine;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(d)</TD><TD STYLE="text-align: justify">each of the Registers, the Director's Certificate and the 2025 Stock Incentive Plan is accurate, complete
and up-to-date (as the case may be) as at the date of this opinion;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(e)</TD><TD STYLE="text-align: justify">the Memorandum and Articles provided to us are in full force and effect and have not been amended, varied,
supplemented or revoked in any respect;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(f)</TD><TD STYLE="text-align: justify">all copies of the Form S-8 are true and correct copies and the Form S-8 conforms in every material respect
to the latest drafts of the same produced to us and, where the Form S-8 has been provided to us in successive drafts marked to show changes
from a previous draft, all such changes have been accurately marked;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(g)</TD><TD STYLE="text-align: justify">the Board Resolutions have been duly passed in accordance with the Company's articles of association then
in effect and remains in full force and effect;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(h)</TD><TD STYLE="text-align: justify">each of the directors of the Company has acted in good faith with a view to the best interests of the
Company and has exercised the standard of care, diligence and skill that is required of him or her in approving the 2025 Stock Incentive
Plan and no director has a financial interest in or other relationship to a party of the transactions contemplated by the 2025 Stock Incentive
Plan which has not been properly disclosed in the Board Resolutions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">Page <B><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></B> of <B>4</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(i)</TD><TD STYLE="text-align: justify">neither the directors and shareholders of the Company have taken any steps to wind up the Company or to
appoint a liquidator of the Company and no receiver or restructuring officer has been appointed over any of the Company&rsquo;s property
or assets;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(j)</TD><TD STYLE="text-align: justify">the maximum number of shares (being the Ordinary Shares) which the Company is required to issue under
the 2025 Stock Incentive Plan to fulfil its obligation (the <B>ESOP Shares</B>) will not exceed the Company's authorised share capital
then in place;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(k)</TD><TD STYLE="text-align: justify">the consideration payable for each ESOP Share shall be no less than the par value of the ESOP Shares;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(l)</TD><TD STYLE="text-align: justify">there is nothing under any law (other than the laws of the Cayman Islands), that would or might affect
the opinions herein.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">3</TD><TD STYLE="text-align: justify">Opinions</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">On the basis of the examination of
the Documents and assumptions referred to above and subject to the limitations and qualifications set forth in paragraph 4 below, we are
of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><B>Authorised Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(a)</TD><TD STYLE="text-align: justify">Based solely on the Memorandum, the authorised share capital of the Company is US$50,000 divided into
800,000,000 Ordinary Shares of a nominal or par value of US$0.0000625 each.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt"><B>Valid Issuance
of ESOP Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(b)</TD><TD STYLE="text-align: justify">The ESOP Shares to be issued under the 2025 Stock Incentive Plan have been duly authorised by all necessary
corporate actions of the Company under the Memorandum and Articles and, upon the issuance and delivery of the ESOP Shares in accordance
with the Memorandum and Articles, the Board Resolutions and the terms of the 2025 Stock Incentive Plan and once consideration of not less
than the par value is fully paid per ESOP Share in accordance with the 2025 Stock Incentive Plan to the Company, the ESOP Shares will
be validly issued, fully paid and non-assessable. Once the register of members of the Company has been updated to reflect the issuance
of the ESOP Shares, the shareholders recorded in the register of members of the Company will be deemed to have legal title to the shares
of the Company set out against their respective name.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">4</TD><TD STYLE="text-align: justify">Limitations and Qualifications</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">4.1</TD><TD STYLE="text-align: justify">We offer no opinion:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(a)</TD><TD STYLE="text-align: justify">as to any laws other than the laws of the Cayman Islands, and we have not, for the purposes of this opinion,
made any investigation of the laws of any other jurisdiction, and we express no opinion as to the meaning, validity, or effect of references
in the 2025 Stock Incentive Plan to statutes, rules, regulations, codes or judicial authority of any jurisdiction other than the Cayman
Islands; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(b)</TD><TD STYLE="text-align: justify">except to the extent that this opinion expressly provides otherwise, as to the commercial terms of, or
the validity, enforceability or effect of the Form S-8, the accuracy of representations, the fulfilment of warranties or conditions, the
occurrence of events of default or terminating events or the existence of any conflicts or inconsistencies among the Form S-8 and any
other agreements into which the Company may have entered or any other documents.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">Page <B><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></B> of <B>4</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">4.2</TD><TD STYLE="text-align: justify">Under the Companies Act (Revised) (<B>Companies Act</B>) of the Cayman Islands annual returns in respect
of the Company must be filed with the Registrar of Companies in the Cayman Islands, together with payment of annual filing fees. A failure
to file annual returns and pay annual filing fees may result in the Company being struck off the Register of Companies, following which
its assets will vest in the Financial Secretary of the Cayman Islands and will be subject to disposition or retention for the benefit
of the public of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">5</TD><TD STYLE="text-align: justify">Governing law of this opinion</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">5.1</TD><TD STYLE="text-align: justify">This opinion is:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(a)</TD><TD STYLE="text-align: justify">governed by, and shall be construed in accordance with, the laws of the Cayman Islands;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(b)</TD><TD STYLE="text-align: justify">limited to the matters expressly stated in it; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width:0.5in"></TD><TD STYLE="width:0.5in">(c)</TD><TD STYLE="text-align: justify">confined to, and given on the basis of, the laws and practice in the Cayman Islands at the date of this
opinion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">5.2</TD><TD STYLE="text-align: justify">Unless otherwise indicated, a reference to any specific Cayman Islands legislation is a reference to that
legislation as amended to, and as in force at, the date of this opinion.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width:0.5in">6</TD><TD STYLE="text-align: justify">Reliance</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">We hereby consent to the filing of
this opinion as an exhibit to the Form S-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">This opinion may be used only in connection
with the Form S-8 while the 2025 Stock Incentive Plan is effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Ogier</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ogier</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ea026468001ex10-1_pingan.htm
<DESCRIPTION>2025 STOCK INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Ping An Biomedical Co., Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2025 Stock Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. <U>Purposes of this Plan</U></B>. The purposes
of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants
and to promote the success of the Company&rsquo;s and the Related Entities&rsquo; business. For the avoidance of doubt, this Plan does
not intend to provide incentive to and shall not be applicable to any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2. <U>Definitions</U></B>. The following definitions
shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the
event a term is separately defined in an individual Award Agreement, such definition shall supersede the definition contained in this
Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Administrator</B>&rdquo; means the Board or one or more committees appointed by the Board or another committee (within its delegated authority) to administer all or certain aspects of this Plan. Any such committee shall be comprised solely of one or more directors or such number of directors as may be required under Applicable Laws.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable Laws</B>&rdquo; means the legal requirements relating to this Plan and the Awards under applicable laws, regulations, rules, federal securities laws, state corporate and securities laws, the rules of any applicable stock exchange or national market system, and the laws, regulations, orders or rules of any jurisdiction applicable to the Awards granted to residents therein or the Grantees receiving such Awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Assumed</B>&rdquo; means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing the agreement to assume the Award.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award</B>&rdquo; means the grant of an Option, the direct issuance of Shares or any other right or benefit under this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award Agreement</B>&rdquo; means the written agreement evidencing the grant of an Award executed by the Company and the Grantee, including any amendments thereto.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board</B>&rdquo; means the board of directors of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Termination Event</B>&rdquo; means, the Grantee&rsquo;s: (i) negligence in performing, or refusal to perform, any major duties to the Company or any Related Entity (as stated in the agreement between the Grantee and the Company or any Related Entity, or reasonably assigned by the Company or such Related Entity based on the Grantee&rsquo;s position), or material violation of any code of conduct, rules, regulations, or policies of the Company or any Related Entity, (ii) performance of any act or failure to perform any act in bad faith and to the detriment of the Company or a Related Entity (economical or reputational), (iii) dishonesty or commitment in an act of theft, embezzlement, fraud, or a breach of trust, (iv) any intentional misconduct or material breach of any labor contract (employment agreement), non-disclosure obligation, non-competition obligation, non-solicitation obligation, code of conducts, employee handbook or other agreement between the Grantee and the Company or any Related Entity, (v) leakage of the Company&rsquo;s trade secrets (including without limitation operational and technical information), (vi) breach of a fiduciary duty, or commission of a crime (other than minor traffic violations or similar offenses), (vii) material violation of any Applicable Laws or securities laws, (viii) any intentional act in a manner detrimental to the reputation, business operation, assets, or market image of the Company or any Related Entity, (ix) where the Grantee establishes employment relationship with a second employer while Continuous Service is not yet terminated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo; means Ping An Biomedical Co., Ltd., a company incorporated with limited liability under the laws of the Cayman Islands or any successor corporation that adopts this Plan in connection with a Corporate Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Consultant</B>&rdquo; means any person (other than an Employee or a Director, solely with respect to rendering services in such person&rsquo;s capacity as an Employee or Director) who is engaged by the Company or any Related Entity to render consulting or advisory services to the Company or such Related Entity.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Continuous Service</B>&rdquo; means that the provision of services to the Company or a Related Entity in any capacity of a full-time Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee, Director or Consultant can be effective under Applicable Laws. A Grantee&rsquo;s Continuous Service shall be deemed to have terminated upon an actual termination of Continuous Service, if there has been a change in the entity for which the Grantee provides services, or upon the entity for which the Grantee provides services ceasing to be a Related Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company, any Subsidiary, or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status as long as the individual remains in the service of the Company or a Subsidiary in any capacity of Employee, Director or Consultant (except as otherwise provided in the Award Agreement). An approved leave of absence shall include sick leave or any other authorized personal leave.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Control</B>&rdquo; of a given Person means the power or authority, whether exercised or not, to direct the business, management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; provided, that such power or authority shall conclusively be presumed to exist upon possession of beneficial ownership or power to direct the vote of more than fifty percent (50%) of the votes entitled to be cast at a meeting of the members or shareholders of such Person or power to control the composition of a majority of the board of directors of such Person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Corporate Transaction</B>&rdquo; means (as determined by the Administrator acting reasonably) any of the following transactions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a merger, amalgamation, consolidation or other business combination of the Company with or into any Person, in which the Company is not the surviving entity, or any other transaction or series of transactions, as a result of which the shareholders of the Company immediately prior to such transaction or series of transactions will cease to own a majority of the voting power of the surviving entity immediately after consummation of such transaction or series of transactions, except for a transaction the principal purpose of which is to change the state in which the Company is incorporated;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the sale, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company and its Subsidiaries;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the complete liquidation or dissolution of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer followed by a reverse merger) in which the Company is the surviving entity but (A) the Shares outstanding immediately prior to such merger are converted or exchanged by virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (B) in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company&rsquo;s outstanding securities are transferred to a Person or Persons different from those who held such securities immediately prior to such merger or the initial transaction culminating in such merger, but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquisition in a single or series of related transactions by any Person or related group of Persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&rsquo;s outstanding securities, but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Director</B>&rdquo; means a member of the Board or the board of directors of any Related Entity.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Employee</B>&rdquo; means any person, including a Director, who is in the employment of the Company or any Related Entity, subject to the control and direction of the Company or any Related Entity as to both the work to be performed and the manner and method of performance. The payment of a Director&rsquo;s fee by the Company or a Related Entity shall not be sufficient to constitute &ldquo;employment&rdquo; by the Company or the Related Entity.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exercise Window</B>&rdquo; means such period of time Administrator shall determine in his sole discretion, with reasonable advance notice to Grantees.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Grantee</B>&rdquo; means an Employee, Director or Consultant who receives an Award under this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>M&amp;A</B>&rdquo; means the currently effective memorandum and articles of association of the Company, as amended from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option</B>&rdquo; means an option to purchase Shares pursuant to an Award Agreement granted under this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Parent</B>&rdquo; means any company (other than the Company) in an unbroken chain of companies ending with the Company, if each of the companies (other than the Company) owns or Controls stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other companies in such chain. A company that attains the status of a Parent on a date after the adoption of this Plan shall be considered a Parent commencing as of such date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo; means any individual, corporation, partnership, limited partnership, limited liability company, firm, joint venture, estate, trust, unincorporated organization, association, enterprise, institution, public benefit corporation, entity or governmental or regulatory authority or other entity of any kind or nature.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Plan</B>&rdquo; means this 2025 Stock Incentive Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Registration Date</B>&rdquo; means, in the event of a Corporate Transaction, the date of the consummation of the Corporate Transaction if the same class of securities of the successor corporation (or its Parent) issuable in such Corporate Transaction shall have been sold to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended, on or prior to the date of consummation of such Corporate Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Related Entity</B>&rdquo; means any Subsidiary of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Replaced</B>&rdquo; means that pursuant to a Corporate Transaction the Award is replaced with a comparable share or stock award or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same (or a more favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator and its determination shall be final, binding and conclusive.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Share</B>&rdquo; means the Company&rsquo;s the ordinary shares of a par value of US$0.0000625 each.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Spin-off Transaction</B>&rdquo; means a distribution by the Company to its shareholders of all or any portion of the securities of any Subsidiary of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo; means with respect to a specific entity, (i) any entity (x) more than fifty percent (50%) of whose shares or other interests entitled to vote in the election of directors or (y) more than a fifty percent (50%) interests in whose profits or capital, are owned or Controlled directly or indirectly by the subject entity or through one (1) or more Subsidiaries of the subject entity; (ii) any entity whose assets, or portions thereof, are consolidated with the net earnings of the subject entity and are recorded on the books of the subject entity for financial reporting purposes in accordance with U.S. GAAP; or (iii) any entity with respect to which the subject entity has the power to otherwise direct the business and policies of that entity directly or indirectly through another Subsidiary.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3. <U>Shares Subject to this Plan</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Shares to be issued pursuant to the Awards under this Plan shall be authorized, but unissued, or reacquired Shares. Subject to the provisions of Section 9 below, the maximum aggregate number of Shares that may be issued pursuant to all Awards is 4,050,000 Shares (proportionally adjusted to reflect any share dividends, share splits, or similar transactions).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily) shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under this Plan. Shares that actually have been issued under this Plan pursuant to an Award shall not be returned to this Plan and shall not become available for future issuance under this Plan, except that if unvested Shares are forfeited, or repurchased by the Company, such Shares shall become available for future grant under this Plan. To the extent not prohibited by the Applicable Law and the listing requirements of the applicable stock exchange or national market system on which the Shares are traded, any Shares covered by an Award which are surrendered (i) in payment of the Award exercise or purchase price or (ii) in satisfaction of tax withholding obligations incident to the exercise of an Award shall be deemed not to have been issued for purposes of determining the maximum number of Shares which may be issued pursuant to all Awards under this Plan, unless otherwise determined by the Administrator.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. <U>Administration of this Plan</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan Administrator.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration. This Plan shall be administered by the Administrator. The Administrator may authorize one or more officers or directors of the Company to grant such Awards and may limit such authority as the Administrator determines from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administration Errors. In the event an Award is granted in a manner inconsistent with the provisions of this subsection (a), such Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws and approved by the Administrator.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers of the Administrator. Subject to Applicable Laws and the provisions of this Plan (including any other powers given to the Administrator hereunder), the Administrator shall have the authority, in its discretion:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to determine whether and to what extent Awards are granted hereunder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to determine the type or the number of Awards to be granted, the number of Shares or the amount of consideration to be covered by each Award granted hereunder;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to approve forms of Award Agreements for use under this Plan, to amend terms of the Award Agreements;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to determine or alter the terms and conditions of any Award granted hereunder (including without limitation the vesting schedule and exercise price set forth in the relevant notice of Award or Award Agreement);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to amend the terms of any outstanding Award granted under this Plan, provided that any amendment that would adversely affect the Grantee&rsquo;s rights under an outstanding Award in material aspects shall not be made without the Grantee&rsquo;s written consent;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to construe and interpret the terms of this Plan and Awards, including without limitation, any notice of Award or Award Agreement, granted pursuant to this Plan;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to require the Grantee to provide representation or evidence that any currency used to pay the exercise price of any Award was legally acquired and taken out of the jurisdiction in which the Grantee resides in accordance with the Applicable Laws;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to determine whether and at what price to repurchase from the Grantee all or any portion of the Shares obtained by the Grantee upon exercise of any Awards; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to take such other action, not inconsistent with the terms of this Plan and the Applicable Laws, as the Administrator deems appropriate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification. In addition to such other rights of indemnification as they may have as members of the Board or Employees of the Company or a Related Entity, members of the Board and any Employees of the Company or a Related Entity to whom authority to act for the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company to the extent permitted by Applicable Law and in the manner approved by the Administrator, on an after-tax basis, against all reasonable expenses, including attorneys&rsquo; fees, actually and necessarily incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with this Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by the Company) or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding that such Person is liable for gross negligence, bad faith or intentional misconduct; provided, however, that within thirty (30) days after the institution of such claim, investigation, action, suit or proceeding, such Person shall offer to the Company, in writing, the opportunity at the Company&rsquo;s expense to defend the same.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. <U>Eligibility</U></B>. Awards may be granted
to Employees, Directors and Consultants. An Employee, Director or Consultant who has been granted an Award may, if otherwise eligible,
be granted additional Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. <U>Terms and Conditions of Awards</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Types of Awards. The Administrator is authorized under this Plan to award any type of arrangement to an Employee, Director or Consultant that is not inconsistent with the provisions of this Plan and that by its terms involves or might involve (i) the issuance of an Option or any other similar right with a fixed or variable price of the Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions; or (ii) the issuance of Shares directly, either through immediate purchase of such Shares or as a bonus.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designation of Award. Each Award shall be designated in the Award Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions of Award. Subject to the terms of this Plan, the Administrator shall determine the provisions, terms, and conditions of each Award including, but not limited to, the Award vesting schedule, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of any performance criteria. Each Award shall be subject to Applicable Laws and the terms of an Award Agreement approved by the Administrator. The performance criteria may be applicable to the Company, Related Entities and/or any individual business units of the Company or any Related Entity.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions and Other Transactions. The Administrator may issue Awards under this Plan in settlement, assumption or substitution for, outstanding awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity, an interest in another entity or an additional interest in a Related Entity whether by merger, share purchase, asset purchase or other form of transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separate Programs. The Administrator may establish one or more separate programs under this Plan for the purpose of issuing particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term of Award. The term of each Award shall be the term stated in the Award Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-transferability of Award. The Grantee shall not transfer, sell, hypothecate, encumber or otherwise dispose of any Shares, any Award, or any right or interest under this Plan without first obtaining the prior written consent of the Company and complying with the provisions of any applicable provisions of the M&amp;A.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time of Granting Awards. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the determination to grant such Award, or such other date as is determined by the Administrator.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. <U>Award Exercise or Purchase Price, Consideration
and Taxes</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise or Purchase Price. The exercise or purchase price, if any, for an Award shall be determined by the Administrator. Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue such Award, provided that the exercise or purchase price for the Shares shall be no less than the aggregate par value of such Shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued pursuant to an Award including the method of payment, shall be determined by the Administrator. In addition to any other types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration for Shares issued pursuant to an Award the following:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">check;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the exercise or purchase occurs on or after the Registration Date, or as otherwise permitted by the Administrator, surrender of Shares or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require which have a value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which said Award shall be exercised;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with respect to Options, if the exercise occurs on or after the Registration Date, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any combination of the foregoing methods of payment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Administrator may at any time or from time to time, by adoption of or by amendment to the standard forms of Award Agreement described in Section 4(b)(iv), or by other means, grant Awards which do not permit all of the foregoing forms of consideration to be used in payment for the Shares or which otherwise restrict one or more forms of consideration.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes. No Shares shall be delivered under this Plan to any Grantee or other Person until such Grantee or other Person has made arrangements acceptable to the Administrator for the satisfaction of any income and employment tax withholding obligations under any Applicable Laws. The Grantee shall be responsible for all taxes associated with the receipt, vest, exercise, transfer and disposal of the Awards and the Shares. Upon exercise of an Award, the Company and/or the Related Entity which is an employer of the Grantee shall have the right to withhold or collect from Grantee an amount sufficient to satisfy such tax obligations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>8. <U>Exercise of Award</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Procedure for Exercise; Rights as a Shareholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the terms of this Plan and specified in the Award Agreement. Any Award granted hereunder that has been vested may be exercised only during an Exercise Window.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 34px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company, during an Exercise Window, in accordance with the terms of the Award by the Person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase price as provided in Section 7(b)(iv).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Exercise in Violation of Applicable Law. Notwithstanding the foregoing, regardless of whether an Award has otherwise become exercisable, the Award shall not be exercised if the Administrator (in its sole discretion) determines that an exercise would violate any Applicable Laws.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restrictions on Exercise. Notwithstanding the foregoing, regardless of whether an Award has become vested and exercisable, no Award may be exercised until after the Registration Date (subject to any further blackout/silence period as required by law).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>9. <U>Conditions Upon Issuance of Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares shall not be issued pursuant to the exercise of an Award unless the exercise of such Award and the issuance and delivery of such Shares pursuant thereto shall comply with all Applicable Laws, the M&amp;A and the relevant Award Agreement, and shall be further subject to the approval of counsel for the Company with respect to such compliance.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the exercise of an Award, the Company may require the Person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the exercise of an Award, the applicable Award Agreement may require the Grantee to grant a power of attorney to the Board or any Person designated by the Board to exercise the voting rights with respect to the Shares and the Company may require the Person exercising such Award to acknowledge and agree to be bound by the provisions of the currently effective M&amp;A and other documents of the Company in relation to the Shares (if any, including any Investor Rights Agreement), as if the Grantee is a holder of Shares thereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>10. <U>Termination</U></B>. Upon termination
of the Grantee&rsquo;s Continuous Service for any reason, or upon occurrence of any Termination Event (without regard to whether Grantee&rsquo;s
Continuous Service terminates), all Awards, whether vested or unvested, will be terminated immediately without further effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>11. <U>Adjustments Upon Changes in Capitalization</U></B>.
Subject to any required action by the shareholders of the Company, the number of Shares covered by each outstanding Award, the number
of Shares which have been authorized for issuance under this Plan but as to which no Awards have yet been granted or which have been returned
to this Plan, the exercise or purchase price of each such outstanding Award, the maximum number of Shares with respect to which Awards
may be granted to any Grantee in any fiscal year of the Company, as well as any other terms that the Administrator determines require
adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting from a share split,
reverse share split, share dividend, combination or reclassification of the Shares, or similar transaction affecting the Shares, (ii)
any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company, or (iii) as the
Administrator may determine in its discretion, any other transaction with respect to Shares including a corporate merger, consolidation,
acquisition of property or equity, separation (including a spin-off or other distribution of shares or property), reorganization, liquidation
(whether partial or complete) or any similar transaction; provided, however that conversion of any convertible securities of the Company
shall not be deemed to have been &ldquo;effected without receipt of consideration.&rdquo; Such adjustment shall be made by the Administrator
and its determination shall be final, binding and conclusive. Except as the Administrator determines, no issuance by the Company of shares
of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason hereof shall be made with
respect to, the number or price of Shares subject to an Award. In the event of a Spin-off Transaction, the Administrator may in its discretion
make such adjustments and take such other action as it deems appropriate with respect to outstanding Awards under this Plan, including
but not limited to: (i) adjustments to the number and kind of Shares, the exercise or purchase price per Share and the vesting periods
of outstanding Awards, (ii) prohibit the exercise of Awards during certain periods of time prior to the consummation of the Spin-off Transaction,
or (iii) the substitution, exchange or grant of Awards to purchase securities of the Subsidiary; provided that the Administrator shall
not be obligated to make any such adjustments or take any such action hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>12. <U>Corporate Transactions</U></B>. In the
event of a Corporate Transaction, each Award can be, as determined by the Administrator, Assumed or Replaced (or without taking any action)
immediately prior to the specified effective date of such Corporate Transaction. All outstanding Awards under this Plan shall terminate
upon the consummation of such Corporate Transaction, provided however that, all such Awards shall not terminate to the extent they are
Assumed or Replaced in connection with the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>13. <U>Effective Date and Term of Plan</U></B>.
This Plan shall become effective upon its adoption by the Board or the Company&rsquo;s shareholders or as otherwise specified by the Board
or the Company&rsquo;s shareholders when adopting this Plan. This Plan shall continue in effect for a term of ten (10) years after the
date of adoption, unless sooner terminated. Subject to Applicable Laws, Awards may be granted under this Plan upon its becoming effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>14. <U>Amendment, Suspension or Termination
of this Plan</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board may at any time amend (including extend the term of this Plan), suspend or terminate this Plan; provided, however, that no such amendment, suspension or termination shall be made without the approval of the Company&rsquo;s shareholders to the extent such approval is required by the M&amp;A, the Applicable Laws or as otherwise determined by the board at the time of adoption of this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Award may be granted during any suspension of this Plan or after termination of this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise determined by the Administrator in good faith, the suspension, amendment or termination of this Plan (including termination of this Plan under Section 12, above) shall not materially adversely affect any rights under Awards already granted to a Grantee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>15. <U>Reservation of Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of this Plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&rsquo;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>16. <U>No Effect on Terms of Employment/Consulting
Relationship</U></B>. This Plan shall not confer upon any Grantee any right with respect to the Grantee&rsquo;s Continuous Service, nor
shall it interfere in any way with his or her right or the right of the Company or any Related Entity to terminate the Grantee&rsquo;s
Continuous Service at any time, with or without cause, and with or without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>17. <U>No Effect on Retirement and Other Benefit
Plans</U></B>. Except as specifically provided in a retirement or other benefit plan of the Company or a Related Entity, Awards shall
not be deemed compensation for purposes of computing benefits or contributions under any retirement plan of the Company or a Related Entity,
and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the
availability or amount of benefits is related to level of compensation. This Plan is not a &ldquo;Retirement Plan&rdquo; or &ldquo;Welfare
Plan&rdquo; under the Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>18. <U>Vesting Schedule</U></B>. The Awards
to be issued to any Grantee at such time prior to the Registration Date shall be subject to the vesting schedule as specified in the Award
Agreement of such Grantee. The Administrator shall have the right to adjust the vesting schedule of the Awards granted to the Grantees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>19. <U>Section 409A</U></B>. This Plan and
all Awards granted hereunder are intended to comply with, or otherwise be exempt from, the requirements of Section 409A of the Inland
Revenue Code (the &ldquo;Code&rdquo;). The Plan and all Awards granted under this Plan shall be administered, interpreted, and construed
in a manner consistent with Section 409A of the Code to the extent necessary to avoid the imposition of additional taxes under Section
409A(a)(1)(B) of the Code. Notwithstanding anything in this Plan to the contrary, in no event shall the Administrator exercise its discretion
to accelerate the payment or settlement of an Award where such payment or settlement constitutes deferred compensation within the meaning
of Section 409A of the Code unless, and solely to the extent that, such accelerated payment or settlement is permissible under Section
1.409A-3(j)(4) of the Treasury Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>20. <U>Holding Company, Trustee, etc</U></B>.
Notwithstanding anything to the contrary in this Plan, any Award Agreement, any notice of award or the terms on which any Award is granted
or vested, any underlying Share of the Awards may, at the Administrator&rsquo;s own discretion, be held by one or more holding companies
or trustees or other nominees (collectively, the &ldquo;Trustees&rdquo;) as designated by the Administrator for the Grantees, and this
Plan may be implemented and administrated by the Administrator through the Trustees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>21. <U>Unfunded Obligation</U></B>. Any amounts
payable to Grantees pursuant to this Plan shall be unfunded and unsecured obligations for all purposes. Neither the Company nor any Related
Entity shall be required to segregate any monies from its general funds, or to create any trusts, or establish any special accounts with
respect to such obligations. The Company shall retain at all times beneficial ownership of any investments, including trust investments,
which the Company may make to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or
any Grantee account shall not create or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related
Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee&rsquo;s creditors in any assets
of the Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes in the
value of any assets that may be invested or reinvested by the Company with respect to this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>22. <U>Non-exclusivity of this Plan</U></B>.
Neither the adoption of this Plan by the Board nor the submission of this Plan to the shareholders of the Company for approval shall be
construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including,
without limitation, the granting of share options or other equity-based awards otherwise than under this Plan, and such arrangements may
be either applicable generally or only in specific cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>23. <U>Other Agreements</U></B>. Notwithstanding
the above, the Administrator may require, as a condition to the grant of and/or the receipt of Shares under an Award, that the Grantee
execute lock-up, shareholder or other agreements, as it may determine in its sole and absolute discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>24. <U>Construction</U></B>. Captions and titles
contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of this Plan. Except when
otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term &ldquo;or&rdquo;
is not intended to be exclusive, unless the context clearly requires otherwise. Masculine pronouns and other words of masculine gender
shall refer to both men and women.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>25. <U>Severability</U></B>. If any provision
of this Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction,
such provision shall be construed or deemed amended to conform to the Applicable Laws in the manner that most closely reflects the original
intent of the Award or this Plan, or if it cannot be construed or deemed amended without, in the determination of the Administrator, materially
altering the intent of this Plan or the Award, such provision shall be construed or deemed stricken as to such jurisdiction and the remainder
of this Plan and any such Award shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>26. <U>Governing Law</U></B>. This Plan is
to be construed in accordance with and governed by the laws of the State of New York, without giving effect to any choice of law rule
that would cause the application of the laws of any jurisdiction other than the laws of the State of New York to the rights and duties
of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ea026468001ex23-1_pingan.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (WWC, P.C.)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex23-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Consent of Independent Registered Public
Accounting Firm</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
of our report dated January 24, 2025 in the Registration Statement on Form S-8, relating to the audit of the consolidated balance sheets
of Ping An Biomedical Co., Ltd. (the &ldquo;Company&rdquo;, previously named &quot;Majestic Ideal Holdings Ltd&quot;) as of September
30, 2024 and 2023, and the related consolidated statements of income and comprehensive income, stockholders&rsquo; equity and cash flows
for each of the years in the two-year period ended September 30, 2024, and the related notes (collectively referred to as the &ldquo;financial
statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the Company&rsquo;s reference
to WWC, P.C., Certified Public Accountants, as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">/s/ WWC, P.C.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>San Mateo, California</TD>
    <TD>WWC, P.C.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>November 10, 2025</TD>
    <TD>Certified Public Accountants</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>PCAOB ID: 1171</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex23-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ea026468001ex-fee_pingan.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FA.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.3a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: b5e7ebc7d2d42c33d5e72282bcbba8dc -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-8</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001897532</ix:nonNumeric>
      <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_004">Fees to be Paid</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001897532</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-07</xbrli:startDate>
          <xbrli:endDate>2025-11-07</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001897532</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-07</xbrli:startDate>
          <xbrli:endDate>2025-11-07</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">S-8</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">Ping An Biomedical Co., Ltd.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 16%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 18%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 7%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_009">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_010">Ordinary Shares, par value $ US$0.0000625</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_011">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">4,050,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">0.6260</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">2,535,300.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">350.12</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 17%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 25%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" id="fee_017" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">2,535,300.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" id="fee_018" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">350.12</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" id="fee_019" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="12" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" id="fee_020" decimals="INF" format="ixt:numdotdecimal" unitRef="USD">350.12</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_021">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Ordinary Shares (&#8220;Ordinary Shares&#8221;) of Ping An Biomedical Co., Ltd. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s 2025 Stock Incentive Plan (&#8220;Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without receipt of consideration which results in an increase in the number of outstanding Ordinary Shares.<br/><br/>Estimated pursuant to Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $0.626 per share, which is the average of the high and low prices of the Ordinary Shares as reported on The Nasdaq Capital Market on November 6, 2025 (rounded up to the nearest cent).<br/><br/>No Fees were previously paid.<br/><br/></ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q '<# 2(  A$! Q$!_\0
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M=NWRR3TSUR!ZUN44@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !\ L$# 2(  A$! Q$!_\0
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M! (((((/((/3!'0]*H!:*0$'H0<=<'-+0 4444 %%%% !1110 4444 %%%%
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M,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOQ3HMYI&K>'M>$QT75[6XC/^A:H+9X[@V,LJQ_:1"ZR&,-L.[%=K3)%+1NH
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MI+%'[LB?'4NPYSA1VH \E_9%_P""B_\ P4\_8;_X*H?"C_@E-_P5@\=?"O\
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M<))23<+Q<>=27*_U:HKX?M_^"BG[*DGPU^*/Q8OO&'C#0O"'P6^#W@'X\?%
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MUZ7Q=!J</CNYBTR+P_+ (9KS]?** /YD_P#@NU_P1\^/?[3_ ,2?@A_P4?\
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M;1_$E@P\->!0+_3K2ZO;CPOX@^(GCS6=.MWM/#FC6$D]TS?T*?$S]H?]K?\
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M1XTJ7LJ<::DY*.!>!5THQBG7I5Y5J=.+5*E*HZ-.-6G2C&E4=.E4:C*G&+_
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M1?M;?^&+F_\ FEK]>**/[%\1?^B_R;_Q7V _^B</[0X6_P"B9Q__ (D^)_\
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M8N;_ .:6OUXHH_L7Q%_Z+_)O_%?8#_Z)P_M#A;_HF<?_ .)/B?\ YSGY#_\
M#Z']FC_HD7[6W_ABYO\ YI:/^'T/[-'_ $2+]K;_ ,,7-_\ -+7Z\44?V+XB
M_P#1?Y-_XK[ ?_1.']H<+?\ 1,X__P 2?$__ #G/R'_X?0_LT?\ 1(OVMO\
MPQ<W_P TM'_#Z']FC_HD7[6W_ABYO_FEK]>**/[%\1?^B_R;_P 5]@/_ *)P
M_M#A;_HF<?\ ^)/B?_G.?D/_ ,/H?V:/^B1?M;?^&+F_^:6C_A]#^S1_T2+]
MK;_PQ<W_ ,TM?KQ11_8OB+_T7^3?^*^P'_T3A_:'"W_1,X__ ,2?$_\ SG/R
M'_X?0_LT?]$B_:V_\,7-_P#-+1_P^A_9H_Z)%^UM_P"&+F_^:6OUXHH_L7Q%
M_P"B_P F_P#%?8#_ .B</[0X6_Z)G'_^)/B?_G.?D/\ \/H?V:/^B1?M;?\
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MUQ+=R^C_  Z\#Z#X2\+P7CDL5EO=9U'6O$&I6.2 \,,FARRJJ@S*,J/[(J3
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M4DJ4%3I4G9\R<H4(4XS:>W/S6LDE8;L'')X.>O4^_'/_ -<TZBBO7. ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M_<QZE_\ )%'_  [N^$__ $+FJ?\ A1ZE_P#)%8^VQW_/N/\ X$__ ) =J/\
M,_N_X)[+_P )!9_\_,'_ '\7_&C_ (2"S_Y^8/\ OXO^->-?\.[OA/\ ]"YJ
MG_A1ZE_\D4?\.[OA/_T+FJ?^%'J7_P D4>VQW_/N/_@3_P#D M1[O[O^">R_
M\)!9_P#/S!_W\7_&C_A(+/\ Y^8/^_B_XUXU_P .[OA/_P!"YJG_ (4>I?\
MR11_P[N^$_\ T+FJ?^%'J7_R11[;'?\ /N/_ ($__D M1[O[O^">R_\ "06?
M_/S!_P!_%_QH_P"$@L_^?F#_ +^+_C7C7_#N[X3_ /0N:I_X4>I?_)%'_#N[
MX3_]"YJG_A1ZE_\ )%'ML=_S[C_X$_\ Y +4>[^[_@GLO_"06?\ S\P?]_%_
MQH_X2"S_ .?F#_OXO^->-?\ #N[X3_\ 0N:I_P"%'J7_ ,D4?\.[OA/_ -"Y
MJG_A1ZE_\D4>VQW_ #[C_P"!/_Y +4>[^[_@GLO_  D%G_S\P?\ ?Q?\:/\
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M3_\ 0N:I_P"%'J7_ ,D4?\.[OA/_ -"YJG_A1ZE_\D4>VQW_ #[C_P"!/_Y
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M\7_&C_A(+/\ Y^8/^_B_XUXU_P .[OA/_P!"YJG_ (4>I?\ R11_P[N^$_\
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M0"U'N_N_X)[+_P )!9_\_,'_ '\7_&C_ (2"S_Y^8/\ OXO^->-?\.[OA/\
M]"YJG_A1ZE_\D4?\.[OA/_T+FJ?^%'J7_P D4>VQW_/N/_@3_P#D M1[O[O^
M">R_\)!9_P#/S!_W\7_&C_A(+/\ Y^8/^_B_XUXU_P .[OA/_P!"YJG_ (4>
MI?\ R11_P[N^$_\ T+FJ?^%'J7_R11[;'?\ /N/_ ($__D M1[O[O^">R_\
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M'ML=_P ^X_\ @3_^0"U'N_N_X)[+_P )!9_\_,'_ '\7_&C_ (2"S_Y^8/\
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M%'J7_P D4>VQW_/N/_@3_P#D M1[O[O^">R_\)!9_P#/S!_W\7_&C_A(+/\
MY^8/^_B_XUXU_P .[OA/_P!"YJG_ (4>I?\ R11_P[N^$_\ T+FJ?^%'J7_R
M11[;'?\ /N/_ ($__D M1[O[O^">R_\ "06?_/S!_P!_%_QH_P"$@L_^?F#_
M +^+_C7C7_#N[X3_ /0N:I_X4>I?_)%'_#N[X3_]"YJG_A1ZE_\ )%'ML=_S
M[C_X$_\ Y +4>[^[_@GLO_"06?\ S\P?]_%_QH_X2"S_ .?F#_OXO^->-?\
M#N[X3_\ 0N:I_P"%'J7_ ,D4?\.[OA/_ -"YJG_A1ZE_\D4>VQW_ #[C_P"!
M/_Y +4>[^[_@GLO_  D%G_S\P?\ ?Q?\:/\ A(+/_GY@_P"_B_XUXU_P[N^$
M_P#T+FJ?^%'J7_R11_P[N^$__0N:I_X4>I?_ "11[;'?\^X_^!/_ .0"U'N_
MN_X)[+_PD%G_ ,_,'_?Q?\:/^$@L_P#GY@_[^+_C7C7_  [N^$__ $+FJ?\
MA1ZE_P#)%'_#N[X3_P#0N:I_X4>I?_)%'ML=_P ^X_\ @3_^0"U'N_N_X)[*
M?$%GQ_I$//\ TT7_ !JU%(LT:NI!5P"".XKP\?\ !.[X4#/_ !3NJ#/IXCU+
M_P"2*]JTC3(=%TJUL[=/+M[2)(8DW%MJJ  ,GD\#O73AYUY?QHI>C;_-(F2A
M]AM^JL6****Z2 HHHH **** "BBB@ HHHH **** "BBB@!KRK&0&.,U&M_"S
M$!QD'&.]8_Q*\0V7A+P3JNJ:EJ8T;3M.LI[JYOR5'V*-$+/-\P*_(H+<@C .
M01P?E/0?C9%%+=S^"?%EU?:7/I+QW5WK/B*+4-2FF,UJPU"UL2TI1(;7[?<-
M$JQ$LJ*8/E 4 ^Q/M\.,^8M"ZA X)$J$ X/->,?";5K+5_'>I:-X?\77'BCP
M[)I+7%W?G44OVTF\,H$869MP8S*9G\O)6+[.N%02#=QW@+QPM]^SA\&WUGQI
M>Q:!X@T""XUOQ')J@6:\O#:0N('N008C,SW#F163!MUC!&]48 ^F3?0@9\Q?
M2D&HP%-PE0KZYKYA^(GC+4;G]GJ[>UUZYOXCXVTO2-"U4:RVEMKUK-J=G R_
M:(!O_P"6MS '529!"L@W;@Y9XFE\;?";4/"I,TT=_J6KWD>D>'I/$L^I-J;Q
MZ+J<Y1[F?RVD5Y8K9@C@^48BP?#@* ?40O8CG#J<4-?0KUD48]3_ )]OS%?*
M&@>/- MO"_@_5?#'Q=USQGXHU;5["UOXIK]9)-7AFN%2Z2730H2S,41ED/EP
MPR1-;;7.#*C\0GQL\2?"[P[>1ZSXDUG6/ _CCXC)INC>(TOV=]$E_P"$J-B^
MES31X9+:2")1'*S'+R31.P+1!@#[F>]B3&7 W8Q[YI6NXUB$A<;",ANV*^-_
MV3?&&C>/+'P3<:WXMCDNK_1#>AH/BC=7KZE,]DWF1S6#LJ@F)YI\#=Y1AW9&
MP,.,\(?%BTUC]DC4O$.H^,1I_B33O 7]LZ=<6WQ7N]0?4KUM,N3()+=RHA9&
M"2?*K8+<8"$$ ^^XKN.:0HCJS*,D>E-DOX(B0TJ KG//3'6O /@#?>(O#'Q[
MOO#^IVEYH\,6A->):7?BR[\0#5]T\:K-;/<J&C6WVNDH0<F[M]W_ "S)YC0/
MB!H6IZ;IFM>)/BIKV@^/I]8^SW&C6EZ&ELYVNW1],72PCI-&F7C\[R&=HX_M
M'FX F !]3?VC!_SU3 .,YXI3>Q#'SCFOE+4/B%HU\GCC4?$WQ:U7PKXQT2^U
M"&ST^/4EB?0[>":=+22+3%&+PRQ*L@\Z*8RF3:F5"*)]3^)=Q9?"#XOV&KZ[
M)X=\>WD?VO2M'&M$7\%U+H5C,L-H-_F.OVUYU41Y#.& SR* /J8WT(&?,7IG
M_/YT->1)G+@!<9)Z5\<-XBU]8]0UNUFGDL[KQSJFAG7V\;7<MKHSC5+FV@:Y
MTPJ86C5UAMQ&"26DC),2EI$[WP7\,M!T+XT:WH]QXX\8FQ\#>']#U=WOO&5[
M,896N-0,KW/FS%2KI9Q[A(-N QXR30!]%?;8N?G'%!O8@N3(N/7->!?M,^/[
M&/5_"MO;^,]%T[3]:BN+M;6;Q)_8::[$J+M:/4$C=U5/,#[(BK2;L[O+259/
M/-:^+%]J?@&P^'WAO6O&.L>)?$%U?SM=Z1J=O?WFE:;;O'))-;7KF!;B)9KF
MTMA(S&4[Y Q+Q2$ 'U]_:4 )'FH",GDT#48"F[S!CUKX\T7X[>+?'?Q3@\8>
M&I;ZYF\,^%[%/%/P]@OXG=Y&O-2MM0\E0Q3[;;3V4:1L7V2(CQEAYBR1Z=Y\
M4[OQW^PO8>)_!'C*<ZMK'C9+?P[J5W?2QBY63Q-]FMX)1)^\,;0[8GB=2P3(
MVAEX /K%=1@=RHE0L#C /T_Q%"ZA [ +*C$\@*<U\@7'[8 TCXA2^.M6GU*T
M\,P^#=2FL_"\EPJ7%W=6]SI<)_<L1_I+7UW<6*[@!OC&.'R=KX+S7WC75-0\
M%_$2_P#&6@ZMHX3Q;%++KHTV6_AFCDAN(4-K<EFM+:XWG:6"HLMF",J"0#ZG
M2[BD;"NK$^E(]Y%&3EU&TX/M_G^H]:^(K'68="TCX0:I+XOU6Z'C?P3)K%Y%
MJWQ+OM(M;J<)IK?:(I0[G/\ I3#RU 4A@>-M=9X:\8^&=4\1:%I>M_$O4M#\
M*G1QJ5@H\8LZZMJ$UW>_;+?^U=XFN/L95(Q$DP"AOG0[$V 'UFLZ.0 P.>F*
M22\BBDVM(@;IC/->,_LW_%*VO;K7-,;Q0=>LO[?N+/PQ<WD\;3ZE:1VMM+(L
M3C!ND@EDFB,HWLPA!=W8,[<+X[^(&B75_P".+_QM\3=9\":[H6IS1V&GVFHB
MTDTV%%B^S/!:A2NH-.GE2@21W 9[@P!<HT0 /I^*]AF*A)$;>,K@YS1)>11.
M5:1%(Z@GI7R7KG[4M_#\78O%-FGB:[^'_@G5(/#.J:AYMK;Z5)).$CO+RYW2
MQL/LLTT"L3%MB^SW@_B!79_:G^*G_"%?%]SK/B66VTAM"@NM&T[3?$5KI]W:
M7\<MSY]Y-!*4,\&PVJ@-YZ%HW7R#DEP#Z:.H0!03(H!(49]?2A-0@?&V5#GI
M@_Y]:^)?BG^V9K>F^#O"=QXGL_$_A.?1G\+3ZH]EI-\TFNZC>2V;7-A#M@*O
M D,\BE=V^24^7M7RG$G2>+?VM9[W]I[P98W3^*M!TQ_&$WA?3M.CTZ]W^(<V
M5VLMW-F$1F".XCB,>UV41*\['#*(P#ZW:_A12S2(%49))X ]?\^E(-1@:15$
MJEF.!C\?\*^3++XI31^!/#&IQ?$BZTKQ1XAL7/B[-S;7)\-$:;<3"46<BM':
M>1<K% 1Y:AS(%E$DI4CJ?V0_B=<Z]\0;C2FU[3?$5G>Z/!J44^E>(Y/$-M'.
M'99I'N75?)$P>(Q6ZDKB"5@%YW 'T8]U'&Q4L P&2.]-^WP[U7S%W,,A>Y'T
M_P ]*YGXL_#33OB+IEF=4U77=+M=(N#?,^FZO/IN_$,D9$KPNC&,"0MM)QN5
M3_"*^2(-3@T[0OA!J<_C'5;I/'?@F36+V'5OB1?:5:7-PJZ:YN(Y0[DMBZD&
MP?*0P/&V@#[>CO8I9 BR*6(R!4M?+_[/'QN\%>!O&>LP:A\1]-CTL>'M-U7R
M]6\;#4XK.YEO=7-VB3S2G<(C&D1QC:L" XQ7M?B+XI6A\9:/I>E>)?"J3KK;
M:7J=E/()[N>3^S9;P6<(653'=",P71#*Y^S)(=@#K(@!V,EU'%(%9U5CT!/)
MIIOX5ZR*/J<5\C_M&_$[Q>OQAN-+AU7^P_#NH>*SH-_J]S?M:V6F6T>@0WL4
M$FW#*)9[BX)D22%V9(D\X#9&W)/XHUSQ)XG\.:7/\0K/1](LDUJW_MB_\1ZD
M++6?*N+7R7MY()+99-ADE0K-<O*I\P9G$7G4 ?<WVZ'&?,7'?V_SS^1IR3H\
M1<,-HZGTKY)\"_%"'6_ J3>)O&.H> Y=&TFV'AU#K1OI-2CCAV#4O-=0^IF2
M1'4)(C,P2-S$K3 MVGP.^)GC":V^*MJ-_B'5]%AM=0BTB65-VA:M<Z9'<S:&
M9\_.%<Q7"N[-L34D12(XXU4 ]_&H0$_ZU/SI&U*!03YBD#CCFOB'X/\ Q5US
M6?#V@:MJ7Q/-O=>+O#$M]K=Q!JD=S<>%YQ;))YUW9W$;6XVR'RR(H;4(Y$;0
MR[R8FW/[0&L>']/;3;?Q!8ZY;ZW)ITDUWIOC&>^L+4O,Z74MSJHCW:>DR/%Y
M*1AEW6[A1'YA:@#[C%Y$R[@ZD>HIG]IP;<^8I'3CG-?)7@/XY^*-*T#QW8Z1
M:ZIJ%EILULEOK-AK \2Z?H=N\:&YNFN[C;+<31J99/LZQR[?*B'27 A^+7Q>
MD\%O!8^#O%USXP\/ZI-9IJE]+X@\NWTF628*PEU--TENLT8G;Y=WE/!$@6)9
MU- 'UY]OAQGS%Q@G/;CKS1_:,&X+YJY)V@9Y)]/K7QY\.OB_>7OC74/#^K>(
MIM"\"V]XH?6+/Q1)JMM*QME>.S_M64+*KNPG=L$>4+>)1)_I 2JWB#XPZCJO
MC^/0[G64U+PI;PW4NEZS>^+I?#$.M1K,B(Z7-NI-RT;-<Q,IP,112Y?S@] '
MV?%.DZ%D8,!UQ],_R(I([J.525=6"G!([5YQ^R9XPO\ X@_LY>'M5U03_;[J
MW<3F9B^]E=E+*Y ,L9QE)2 94*R8&_ \HU+PQKOQA^,GQ&TRSO-6N-/T_6[3
M3;B>T\=ZEIDVC6\FF6$KB*UM_D+8EED5F92SR=,+R ?3QO(ESEU&.O\ G\1^
M8I&OH4(!D4$G !_S[C\Z^3S^T_<M\;V\:%=;A^&-MJS^"'U2:ZM8]&0K<"![
MTYF$OF#4U^Q@F/:$^=3M8L3X._'*RT;X@:;=^)?&RZ?X&M=&O=1\$ZG>:WFT
M\8Z:(X+F[U&ZFD.UI+9,^7EL&WDDN,MEA;@'UJ3@5$+^%@2)48#N#FO*_BA\
M5M6T?X3?%_4M-UG0KN^\)VEXU@EC#F?1I$TN&X2&[W2.K3[W\X92,>3/ "AP
M7?YWU;XA>*].^('BXWWB&31Y_ _B.#2]"\-RZ^ZZEJUD([(QO ""DYG#[O\
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M5=!NHVCM-+T=6TW5K0DFYL[R.4L624K 0ZD/$8%*%2S9 ,T?&"._\)+:Z?\
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MFM.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001897532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Ping An Biomedical Co., Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Nov. 07, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Ordinary Shares, par value $ US$0.0000625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">4,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.6260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,535,300.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 350.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Ordinary Shares (&#8220;Ordinary Shares&#8221;) of Ping An Biomedical Co., Ltd. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s 2025 Stock Incentive Plan (&#8220;Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without receipt of consideration which results in an increase in the number of outstanding Ordinary Shares.<br/><br/>Estimated pursuant to Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $0.626 per share, which is the average of the high and low prices of the Ordinary Shares as reported on The Nasdaq Capital Market on November 6, 2025 (rounded up to the nearest cent).<br/><br/>No Fees were previously paid.<br/><br/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 07, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,535,300.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">350.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 350.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea026468001ex-fee_pingan.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea026468001ex-fee_pingan.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea026468001ex-fee_pingan.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea026468001ex-fee_pingan.htm">ea026468001ex-fee_pingan.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea026468001ex-fee_pingan.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea026468001ex-fee_pingan.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 19,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea026468001ex-fee_pingan.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-108445-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-108445-xbrl.zip
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M1Y [S@:'*0EXRQ@Y&W:YP>6_)GXG]5IN:(EE5*X 01MPI@12!B>1DC.+2R\
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M' DF@SX"LH^E$)P6A"S',PAB,9,[U!9A^S#)N=MS+$_&R^M96U>J>QFUJ&;
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MH=E!&VM&O:Z^:=3GP[NE1?=E99"O%G!J9\COS.XS=(L,:5%79.,[)+"^%X#
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MP/K<ZPE0CD^Y-0$V=_@9G4GXG5)R*L$!A=]4XT&%GUM7_PU02P$"% ,4
M" #HIFI;:4EH*/P*  !T,@  '               @ $     96$P,C8T-C@P
I,#%E>"UF965?<&EN9V%N+FAT;5!+!08      0 ! $H    V"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea026468001ex-fee_pingan_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001897532</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-07</startDate>
            <endDate>2025-11-07</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001897532</identifier>
        </entity>
        <period>
            <startDate>2025-11-07</startDate>
            <endDate>2025-11-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001897532</dei:EntityCentralIndexKey>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_004">false</ffd:PrevslyPdFlg>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">Ping An Biomedical Co., Ltd.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_009">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_010">Ordinary Shares, par value $ US$0.0000625</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_1" id="fee_011">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_012"
      unitRef="shares">4050000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="USD">0.6260</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_014"
      unitRef="USD">2535300.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">350.12</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_017"
      unitRef="USD">2535300.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_018"
      unitRef="USD">350.12</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_019"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_020"
      unitRef="USD">350.12</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_021">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this Registration Statement shall also cover any additional shares of Ordinary Shares (&#x201c;Ordinary Shares&#x201d;) of Ping An Biomedical Co., Ltd. (the &#x201c;Registrant&#x201d;) that become issuable under the Registrant&#x2019;s 2025 Stock Incentive Plan (&#x201c;Plan&#x201d;) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without receipt of consideration which results in an increase in the number of outstanding Ordinary Shares.&lt;br/&gt;&lt;br/&gt;Estimated pursuant to Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $0.626 per share, which is the average of the high and low prices of the Ordinary Shares as reported on The Nasdaq Capital Market on November 6, 2025 (rounded up to the nearest cent).&lt;br/&gt;&lt;br/&gt;No Fees were previously paid.&lt;br/&gt;&lt;br/&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
